Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04-Reference-Cited by-同舟云学术

Multimodal treatment including standard chemotherapy with vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for the Ewing sarcoma family of tumors in Japan: Results of the Japan Ewing Sarcoma Study 04

Published:2020-05 Issue:5 Volume:67 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Chin Motoaki¹^ORCID,Yokoyama Ryohei²,Sumi Minako³,Okita Hajime⁴,Kawai Akira⁵,Hosono Ako⁶,Koga Yuhki⁷^ORCID,Sano Hideki⁸^ORCID,Watanabe Hiroyoshi⁹,Ozaki Toshifumi¹⁰,Mugishima Hideo¹¹,

Affiliation:

1. Department of PediatricsNihon University School of Medicine Tokyo Japan

2. Department of Orthopedic SurgeryNational Hospital Organization Kyushu Cancer Center Fukuoka Japan

3. Cancer Institute Hospital‐JFCR Tokyo Japan

4. Department of PathologyKeio University School of Medicine Tokyo Japan

5. Department of Musculoskeletal Oncology and Rehabilitation MedicineNational Cancer Center Hospital Tokyo Japan

6. Department of Pediatric OncologyNational Cancer Center Hospital East Kashiwa Japan

7. Department of Pediatric Medicine for Hospital Collaboration, Graduate School of Medical, SciencesKyushu University Fukuoka Japan

8. Department of Pediatric OncologyFukushima Medical University Hospital Fukushima Japan

9. Department of Pediatrics Graduate School of Medical SciencesTokushima University Tokushima Japan

10. Department of Orthopedic SurgeryOkayama University Hospital Okayama Japan

11. Kawagoe Preventive Medical Center Clinic Saitama Japan

Funder

Ministry of Health, Labor and Welfare Fund

National Cancer Center Research and Development Fund

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.28194

Reference17 articles.

1. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: a long-term follow-up of the First Intergroup study.

2. Long-term results from the first UKCCSG Ewing's tumour study (ET-1)

3. Treatment of Ewing sarcoma family of tumors: Current status and outlook for the future

4. Clinical outcome of patients with Ewing sarcoma family of tumors of bone in Japan

5. Addition of Ifosfamide and Etoposide to Standard Chemotherapy for Ewing's Sarcoma and Primitive Neuroectodermal Tumor of Bone

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Respiratory insufficiency after brain metastasectomy for extraskeletal Ewing sarcoma in an adult patient with mucopolysaccharidosis type II: a case report;International Cancer Conference Journal;2024-07-09

2. Effectiveness and safety of primary prophylaxis with G-CSF for patients with Ewing sarcomas: a systematic review for the Clinical Practice Guidelines for the Use of G-CSF 2022 of the Japan Society of Clinical Oncology;International Journal of Clinical Oncology;2024-06-21

3. Histological diagnostic discrepancy and its clinical impact in bone and soft tissue tumors referred to a sarcoma center;Cancer Science;2024-05-19

4. Quercetin mitigates doxorubicin-induced neurodegenerative changes in the cerebral cortex and hippocampus of rats; insights to DNA damage, inflammation, synaptic plasticity;Tissue and Cell;2024-04

5. AURKA inhibition induces Ewing’s sarcoma apoptosis and ferroptosis through NPM1/YAP1 axis;Cell Death & Disease;2024-01-29